For citations:
Israelyan E.R., Tryakin A.A., Rumyantsev A.A., Fedyanin M.Yu., Kononets P.V., Gerasimov S.S., Matveev V.B., Volkova M.I., Klimov A.V., Semenova A.I., Paichadze A.A., Tsareva A.S., Yunaev G.S., Tjulandin S.A. TIP regimen (paclitaxel, ifosfamide, cisplatin) in nonseminomatous germ cell tumors with poor-prognosis and unfavorable decline of serum tumor markers: final results. Malignant tumours. 2025;15(1):7-16. (In Russ.) https://doi.org/10.18027/2224-5057-2025-034
Email this article 